Paul Dick

Private Equity Investor at

Vet Venture Capital, Inc.

Consumer Services

Commercial Services

Finance

Profile

Paul Dick is currently a Partner at Vet Venture Capital, Inc. He was previously the Chief Executive Officer & Director at Avivagen, Inc. from 2008 to 2010.
He also served as a Director at AbCelex Technologies, Inc. Dr. Dick holds a doctorate degree from the University of Guelph.

Paul Dick active positions

Companies	Position	Start
Vet Venture Capital, Inc. Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement.	Private Equity Investor	-

All active positions of Paul Dick

Former positions of Paul Dick

Companies	Position	End
AVIVAGEN INC.	President	01/10/2010
AbCelex Technologies, Inc. AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Director/Board Member	-

See the detail of Paul Dick's experience

Training of Paul Dick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Dick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Guelph University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avivagen, Inc. Avivagen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes health supplements for animals & pets	Commercial Services
Vet Venture Capital, Inc. Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement.	Finance
AbCelex Technologies, Inc. AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology

See company connections